This decision follows the authorization by the U.S. Food & Drugs Administration (FDA) of the Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 Vaccine.
These updated recommendations apply to certain immunocompromised individuals and people over the age of 50 who received an initial booster dose at least 4 months ago.
Click here to learn more.
Skip to content